ATE503748T1 - Anti-krebs- und antimikrobielle oxazolidinone und analoga - Google Patents
Anti-krebs- und antimikrobielle oxazolidinone und analogaInfo
- Publication number
- ATE503748T1 ATE503748T1 AT06735789T AT06735789T ATE503748T1 AT E503748 T1 ATE503748 T1 AT E503748T1 AT 06735789 T AT06735789 T AT 06735789T AT 06735789 T AT06735789 T AT 06735789T AT E503748 T1 ATE503748 T1 AT E503748T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- oxazolidinones
- analogues
- antimicrobial
- analogs
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001093 anti-cancer Effects 0.000 title abstract 2
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- PXHFLWCSJYTAFU-UHFFFAOYSA-N 1,3-oxazolidin-4-one Chemical class O=C1COCN1 PXHFLWCSJYTAFU-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical compound O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/40—One oxygen atom attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/04—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers
- C07C257/06—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines without replacement of the other oxygen atom of the carboxyl group, e.g. imino-ethers having carbon atoms of imino-carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms, or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65560505P | 2005-02-22 | 2005-02-22 | |
| PCT/US2006/006278 WO2006091669A1 (en) | 2005-02-22 | 2006-02-22 | Anti-cancer and anti-microbial oxazolidinones and analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE503748T1 true ATE503748T1 (de) | 2011-04-15 |
Family
ID=36580024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06735789T ATE503748T1 (de) | 2005-02-22 | 2006-02-22 | Anti-krebs- und antimikrobielle oxazolidinone und analoga |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US7378530B2 (de) |
| EP (1) | EP1856066B1 (de) |
| JP (1) | JP2008531573A (de) |
| KR (1) | KR20070106578A (de) |
| CN (1) | CN101160294A (de) |
| AT (1) | ATE503748T1 (de) |
| AU (1) | AU2006216708A1 (de) |
| BR (1) | BRPI0607974A2 (de) |
| CA (1) | CA2597667A1 (de) |
| DE (1) | DE602006020992D1 (de) |
| IL (1) | IL185266A0 (de) |
| MX (1) | MX2007009990A (de) |
| WO (1) | WO2006091669A1 (de) |
| ZA (1) | ZA200707855B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7378530B2 (en) * | 2005-02-22 | 2008-05-27 | Nereus Pharmaceuticals, Inc. | Anti-cancer and anti-microbial 5-membered heterocyclic compounds |
| US20110118274A1 (en) * | 2007-08-23 | 2011-05-19 | Cornell Research Foundation, Inc. | Proteasome inhibitors and their use in treating pathogen infection and cancer |
| FR2948940B1 (fr) * | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| IN2015DN00961A (de) * | 2012-10-29 | 2015-06-12 | Hoffmann La Roche | |
| EP3317268B1 (de) * | 2015-07-03 | 2019-08-28 | Bayer CropScience Aktiengesellschaft | Herbizid wirksame n-(tetrazol-5-yl)- und n-(triazol-5-yl)arylcarboxamid-derivate |
| UA123628C2 (uk) * | 2015-07-03 | 2021-05-05 | Баєр Кропсаєнс Акціенгезельшафт | Гербіцидно активні похідні n-(1,3,4-оксадіазол-2-іл)арилкарбоксаміду |
| WO2018039244A1 (en) | 2016-08-22 | 2018-03-01 | North Carolina State University | 5-benzylidene-4-oxazolidinones |
| WO2018039242A1 (en) | 2016-08-22 | 2018-03-01 | North Carolina State University | 4-oxazolidinone antimicrobial agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2915527A (en) | 1959-12-01 | Oxazolidone compounds and means for | ||
| US2971958A (en) | 1959-03-17 | 1961-02-14 | Union Carbide Corp | Cyanoethylated oxalactams |
| US3129222A (en) | 1960-12-01 | 1964-04-14 | Merck & Co Inc | 2, 2, 5-trisubstituted-4-oxazolidinone compounds |
| US3182063A (en) | 1961-03-06 | 1965-05-04 | Warner Lambert Pharmaceutical | Substituted 4-thiazolidinones and process therefor |
| DE1917615U (de) | 1963-02-15 | 1965-06-10 | Kloeckner Humboldt Deutz Ag | Rotationskolbenmaschine. |
| DE1916715A1 (de) | 1969-04-01 | 1970-10-08 | Goedecke Ag | Verfahren zur Herstellung von Oxazolidon-(4)-Derivaten |
| US4049816A (en) | 1975-03-24 | 1977-09-20 | Beecham Group Limited | Antiviral 2-amino-5-[1-(indol-3-yl)alkyl]-2-thiazolin-4-ones |
| US4584385A (en) | 1984-03-22 | 1986-04-22 | Pfizer Inc. | Antibacterial 2-amino-oxazolinones and process therefor |
| US4769232A (en) | 1984-03-22 | 1988-09-06 | Pfizer Inc. | Parenteral formulations of indolmycin |
| US4650512A (en) | 1984-09-27 | 1987-03-17 | Stauffer Chemical Company | Oxazolidone herbicides and methods of use |
| US4629794A (en) | 1985-02-04 | 1986-12-16 | Pfizer Inc. | Antibacterial 2-amino-oxazolinones and process therefor |
| US5677463A (en) | 1996-11-20 | 1997-10-14 | Abbott Laboratories | Process for the preparation of 2-imino-5-phenyl-4 oxazolidinone and its intermediates |
| EP1103600A4 (de) | 1998-07-30 | 2002-11-06 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von indolmycin |
| US7378530B2 (en) | 2005-02-22 | 2008-05-27 | Nereus Pharmaceuticals, Inc. | Anti-cancer and anti-microbial 5-membered heterocyclic compounds |
-
2006
- 2006-02-21 US US11/358,961 patent/US7378530B2/en not_active Expired - Fee Related
- 2006-02-22 AU AU2006216708A patent/AU2006216708A1/en not_active Abandoned
- 2006-02-22 DE DE602006020992T patent/DE602006020992D1/de not_active Expired - Lifetime
- 2006-02-22 CN CNA2006800120083A patent/CN101160294A/zh active Pending
- 2006-02-22 MX MX2007009990A patent/MX2007009990A/es active IP Right Grant
- 2006-02-22 JP JP2007557124A patent/JP2008531573A/ja not_active Withdrawn
- 2006-02-22 CA CA002597667A patent/CA2597667A1/en not_active Abandoned
- 2006-02-22 EP EP06735789A patent/EP1856066B1/de not_active Expired - Lifetime
- 2006-02-22 AT AT06735789T patent/ATE503748T1/de not_active IP Right Cessation
- 2006-02-22 WO PCT/US2006/006278 patent/WO2006091669A1/en not_active Ceased
- 2006-02-22 BR BRPI0607974-1A patent/BRPI0607974A2/pt not_active IP Right Cessation
- 2006-02-22 KR KR1020077021734A patent/KR20070106578A/ko not_active Ceased
-
2007
- 2007-08-14 IL IL185266A patent/IL185266A0/en unknown
- 2007-09-14 ZA ZA200707855A patent/ZA200707855B/xx unknown
-
2008
- 2008-05-21 US US12/124,896 patent/US20080221182A1/en not_active Abandoned
- 2008-05-21 US US12/124,909 patent/US7879892B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070106578A (ko) | 2007-11-01 |
| ZA200707855B (en) | 2008-09-25 |
| EP1856066B1 (de) | 2011-03-30 |
| IL185266A0 (en) | 2008-02-09 |
| AU2006216708A1 (en) | 2006-08-31 |
| JP2008531573A (ja) | 2008-08-14 |
| EP1856066A1 (de) | 2007-11-21 |
| US20060205799A1 (en) | 2006-09-14 |
| BRPI0607974A2 (pt) | 2010-08-17 |
| US20080221182A1 (en) | 2008-09-11 |
| CN101160294A (zh) | 2008-04-09 |
| US7378530B2 (en) | 2008-05-27 |
| CA2597667A1 (en) | 2006-08-31 |
| US20080221183A1 (en) | 2008-09-11 |
| DE602006020992D1 (de) | 2011-05-12 |
| US7879892B2 (en) | 2011-02-01 |
| WO2006091669A1 (en) | 2006-08-31 |
| MX2007009990A (es) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200707855B (en) | Anti-cancer and antimicrobial oxazolidinones and analogues | |
| GEP20156309B (en) | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 | |
| JOP20200130A1 (ar) | مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية | |
| CO5570678A2 (es) | N-alquilo-4-metileneamino-3-hidroxilo-2-piridonas como anti- microbianos | |
| MX2009010642A (es) | Antibioticos de oxazolidinona. | |
| BRPI0717266A2 (pt) | Derivados de oxindol | |
| WO2007023507A3 (en) | Oxazolidinones bearing antimicrobial activity composition and methods of preparation | |
| CU23423B7 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea | |
| ATE530561T1 (de) | 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion | |
| ECSP12011880A (es) | INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA | |
| BRPI0414694A (pt) | pró-fármaco(s) aciloximetilcarbamato de oxazolidinonas | |
| MX2010008921A (es) | Derivados de oxazolidinona. | |
| EA201070169A1 (ru) | 2,3-дигидробензо[1,4]диоксин-2-илметиловые производные в качестве альфа2с антагонистов для применения в лечении заболеваний перифирической центральной нервной системы | |
| SV2008002958A (es) | Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania referencia cruzada ref. prd2592sv | |
| NO20081005L (no) | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents | |
| PE20090160A1 (es) | COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA | |
| EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
| EA200601777A1 (ru) | Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии | |
| MX391911B (es) | Compuesto antimicrobiano ((2r,3s,5r)-5-(4-amino-2-oxopirimidin-1(2h)- il)-3-((butoxióxidofosfor-il)oxi) tetrahidrofuran-2-il)metil butil fosfato, y el uso del mismo en infecciones. | |
| BR112013014189A8 (pt) | composição farmacêutica, uso de um agente de potencialização e uso de uma composição | |
| RU2011153353A (ru) | Кетолидные соединения, обладающие противомикробной активностью | |
| CY1115690T1 (el) | Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων | |
| EA200701113A1 (ru) | Макролиды | |
| UA117922C2 (uk) | Насичені азотовмісні та n-ациловані гетероцикли, що посилюють дію активного антибіотика проти мікобактерій | |
| ATE516022T1 (de) | Antimikrobielle zusammensetzungen und anwendungsverfahren dafür |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |